Document Detail

Effect of increasing progesterone concentration from Day 3 of pregnancy on subsequent embryo survival and development in beef heifers.
MedLine Citation:
PMID:  18402756     Owner:  NLM     Status:  MEDLINE    
Higher systemic progesterone in the immediate post-conception period is associated with an increase in embryonic growth rate, interferon-tau production and pregnancy rate in cattle. The objective of this study was to examine the effect of increasing progesterone concentration on Day 3 on subsequent embryo survival and development. Oestrus (Day 0) was synchronised in beef-cross heifers (n=210) and approximately two-thirds of the heifers were inseminated with semen from a proven sire, while the remainder were not inseminated. In order to produce animals with divergent progesterone concentrations, half of the animals received a progesterone-releasing intravaginal device (PRID) on Day 3 of the oestrous cycle, which was left in situ until slaughter. The four treatment groups were: (i) pregnant, high progesterone; (ii) pregnant, normal progesterone; (iii) non-pregnant, high progesterone; and (iv) non-pregnant, normal progesterone. Animals were blood-sampled twice daily from Days 0 to 8 and once daily thereafter until slaughter on Days 5, 7, 13 or 16, corresponding to the 16-cell stage, the blastocyst stage, the beginning of elongation and the day of maternal recognition of pregnancy, respectively. Embryos were recovered by flushing the tract with phosphate-buffered saline and characterised by stage of development and, in the case of Days 13 and 16, measured. Data were analysed by mixed models ANOVA, Chi-square analysis and Student's t-test where appropriate. Insertion of a PRID on Day 3 increased (P<0.05) progesterone concentrations from Day 3.5 onwards. There was no difference between treatments in the proportion of embryos at the expected stage of development on Days 5 or 7 (P>0.05). While not significantly different, the proportion of viable embryos recovered was numerically greater in the high progesterone group on both Day 13 (58 v. 43%) and Day 16 (90 v. 50%). Elevation of progesterone significantly increased embryonic length on Day 13 (2.24+/-0.51 mm v. 1.15+/-0.16 mm, P=0.034) and Day 16 (14.06+/-1.18 cm v. 5.97+/-1.18 cm, P=0.012). In conclusion, insertion of a PRID on Day 3 of the oestrous cycle increased serum progesterone concentrations on subsequent days, which, while having no phenotypic effect on embryonic development on Days 5 or 7, was associated with an increase in embryonic size on Days 13 and 16.
F Carter; N Forde; P Duffy; M Wade; T Fair; M A Crowe; A C O Evans; D A Kenny; J F Roche; P Lonergan
Related Documents :
21394426 - Pregnancy outcomes in japanese patients with sle: retrospective review of 55 pregnancie...
10831556 - Experience with progesterone gel for luteal support in a highly successful ivf programme.
21526636 - The incidence, pattern and management outcomes of early pregnancy losses at the ebonyi ...
21321006 - Fetal alcohol spectrum disorders--a case-control study from india.
16580726 - Paradoxical discrepancy between the serum level and the placental intensity of pp5/tfpi...
6615966 - Further quantification of human spermatogenesis: germ cell loss during postprophase of ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Reproduction, fertility, and development     Volume:  20     ISSN:  1031-3613     ISO Abbreviation:  Reprod. Fertil. Dev.     Publication Date:  2008  
Date Detail:
Created Date:  2008-04-11     Completed Date:  2008-06-26     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8907465     Medline TA:  Reprod Fertil Dev     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  368-75     Citation Subset:  IM    
School of Agriculture, Food Science and Veterinary Medicine, College of Life Sciences, University College Dublin, Belfield, Dublin 4, Ireland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Embryonic Development / drug effects*
Estrous Cycle / physiology*
Gonadal Hormones / blood,  pharmacology*
Pregnancy / physiology*
Pregnancy Outcome
Progesterone / blood,  pharmacology*
Reg. No./Substance:
0/Gonadal Hormones; 57-83-0/Progesterone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Homeodomain protein HLX is expressed primarily in cytotrophoblast cell types in the early pregnancy ...
Next Document:  Miniature ponies: 1. Follicular, luteal and endometrial dynamics during the oestrous cycle.